Literature DB >> 8680668

Exposure-sensitization relationship for alpha-amylase allergens in the baking industry.

R Houba1, D J Heederik, G Doekes, P E van Run.   

Abstract

Fungal alpha-amylase is an important occupational allergen in the bakery industry. Epidemiologic studies focusing on the relationship between alpha-amylase allergen exposure and work-related respiratory allergy, however, have not been reported yet. In this cross-sectional study, sensitization to occupational allergens and work-related symptoms were studied in 178 bakery workers and related to allergen exposure. Alpha-amylase allergen concentrations were measured in personal dust samples, using a sandwich enzyme immunoassay. All workers were categorized into groups on the basis of their job histories and the alpha-amylase exposure levels of their job titles. Of all workers 25% had one or more work-related symptoms. As much as 9% of the bakery workers showed a positive skin prick test reaction to fungal amylase, and in 8% amylase-specific IgE was demonstrated. Alpha-amylase exposure and atopy appeared to be the most important determinants of skin sensitization, with prevalence ratios for atopy of 20.8 (95% CI, 2.74 to 158) and for medium and high alpha-amylase exposure groups of 8.6 (95% CI, 1.01 to 74) and 15.9 (95% CI, 1.95 to 129), respectively. Furthermore, a positive association was found between positive skin prick tests to alpha-amylase and work-related respiratory symptoms. In conclusion, this study has shown that there is a strong and positive relationship between alpha-amylase allergen exposure levels in bakeries and specific sensitization in bakery workers.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8680668     DOI: 10.1164/ajrccm.154.1.8680668

Source DB:  PubMed          Journal:  Am J Respir Crit Care Med        ISSN: 1073-449X            Impact factor:   21.405


  21 in total

1.  Exposure-response relations of alpha-amylase sensitisation in British bakeries and flour mills.

Authors:  M J Nieuwenhuijsen; D Heederik; G Doekes; K M Venables; A J Newman Taylor
Journal:  Occup Environ Med       Date:  1999-03       Impact factor: 4.402

2.  Agents, old and new, causing occupational asthma.

Authors:  C E Mapp
Journal:  Occup Environ Med       Date:  2001-05       Impact factor: 4.402

3.  Occupational IgE sensitisation to phytase, a phosphatase derived from Aspergillus niger.

Authors:  G Doekes; N Kamminga; L Helwegen; D Heederik
Journal:  Occup Environ Med       Date:  1999-07       Impact factor: 4.402

4.  Exposure assessment of high molecular weight sensitisers: contribution to occupational epidemiology and disease prevention.

Authors:  D Heederik; G Doekes; M J Nieuwenhuijsen
Journal:  Occup Environ Med       Date:  1999-11       Impact factor: 4.402

5.  Risk of enzyme allergy in the detergent industry.

Authors:  M Vanhanen; T Tuomi; U Tiikkainen; O Tupasela; R Voutilainen; H Nordman
Journal:  Occup Environ Med       Date:  2000-02       Impact factor: 4.402

6.  Short term exposure to airborne microbial agents during farm work: exposure-response relations with eye and respiratory symptoms.

Authors:  W Eduard; J Douwes; R Mehl; D Heederik; E Melbostad
Journal:  Occup Environ Med       Date:  2001-02       Impact factor: 4.402

Review 7.  Monitoring personal allergen exposure.

Authors:  T O'Meara; E Tovey
Journal:  Clin Rev Allergy Immunol       Date:  2000-06       Impact factor: 8.667

8.  Sensitisation to enzymes in the animal feed industry.

Authors:  M Vanhanen; T Tuomi; U Tiikkainen; O Tupasela; A Tuomainen; R Luukkonen; H Nordman
Journal:  Occup Environ Med       Date:  2001-02       Impact factor: 4.402

Review 9.  Enzymes as occupational and environmental respiratory sensitisers.

Authors:  Xaver Baur
Journal:  Int Arch Occup Environ Health       Date:  2005-04-08       Impact factor: 3.015

10.  Early incidence of occupational asthma among young bakers, pastry-makers and hairdressers: design of a retrospective cohort study.

Authors:  Thomas Rémen; Vincent Coevoet; Dovi-Stéphanie Acouetey; Jean-Louis Guéant; Rosa-Maria Guéant-Rodriguez; Christophe Paris; Denis Zmirou-Navier
Journal:  BMC Public Health       Date:  2010-04-26       Impact factor: 3.295

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.